Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 204 publications
Safety and efficacy of relugolix combination therapy in symptomatic uterine fibroids.
Journal: Facts, views & vision in ObGyn
Published: October 01, 2025
GnRH Antagonists: Current Evidence and Role in Prostate Cancer.
Journal: Archivos espanoles de urologia
Published: August 08, 2025
Preferences between three options for androgen deprivation therapy: a focus group study.
Journal: BJU international
Published: July 31, 2025
Adverse Cardiovascular Outcomes of Individuals Treated with Androgen Deprivation Therapy.
Journal: Urology practice
Published: July 18, 2025
Sequential treatment with relugolix combination therapy in women with symptomatic uterine fibroids that were inadequately managed with 52 mg levonorgestrel intrauterine system: the first report.
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: June 23, 2025
Relugolix's impact on endometriosis-associated pain and quality of life: a meta-analysis of EHP-30 outcomes.
Journal: Frontiers in endocrinology
Published: June 20, 2025
Relugolix for Metastatic Hormone-sensitive Prostate Cancer with Impending Paraplegia.
Journal: Annals of African medicine
Published: May 22, 2025
Relugolix in Monotherapy and Combined Therapy for the Treatment of Uterine Diseases and Its Effects on Bones: A Systematic Review.
Journal: Biomedicines
Published: May 21, 2025
Efficacy and Safety of Oral Gonadotropin-Releasing Hormone Antagonist, Relugolix, in Endometriosis: A Meta-Analysis of Randomized Clinical Trials.
Journal: American journal of therapeutics
Published: May 08, 2025
Relugolix in prostate cancer therapy: Clinical evidence and practical considerations.
Journal: The French journal of urology
Published: May 04, 2025
Last Updated: 10/31/2025